Zobrazeno 1 - 10
of 26
pro vyhledávání: '"David J Marchant"'
Publikováno v:
ACS Omega, Vol 9, Iss 20, Pp 22213-22229 (2024)
Externí odkaz:
https://doaj.org/article/818a8c2852544947ba613c30994915ad
Autor:
Ryley D. McClelland, Yi-Chan James Lin, Tyce N. Culp, Ryan Noyce, David Evans, Tom C. Hobman, Vanessa Meier-Stephenson, David J. Marchant
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
IntroductionThe COVID-19 pandemic was caused by the zoonotic betacoronavirus SARS-CoV-2. SARS-CoV-2 variants have emerged due to adaptation in humans, shifting SARS-CoV-2 towards an endemic seasonal virus. We have termed this process ‘virus domesti
Externí odkaz:
https://doaj.org/article/8a834cf72cf643a2b2c319f1778d5372
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
Viruses are diverse pathogens that use host factors to enter cells and cause disease. Imaging the entry and replication phases of viruses and their interactions with host factors is key to fully understanding viral infections. This review will discus
Externí odkaz:
https://doaj.org/article/c02e17275da34cf3ae5e61b5dcaaa460
Autor:
Anissa Viveiros, Ryan S. Noyce, Mahmoud Gheblawi, Daniele Colombo, Leanne M. Bilawchuk, Xavier Clemente-Casares, David J. Marchant, Zamaneh Kassiri, Franca Del Nonno, David H. Evans, Gavin Y. Oudit
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 323:H1262-H1269
Myocardial pathologies resulting from SARS-CoV-2 infections are consistently rising with mounting case rates and reinfections; however, the precise global burden is largely unknown and will have an unprecedented impact. Understanding the mechanisms o
Autor:
Frederic Reicherz, Rui Yang Xu, Bahaa Abu-Raya, Abdelilah Majdoubi, Christina Michalski, Liam Golding, Aleksandra Stojic, Marina Vineta, Madison Granoski, Zenon Cieslak, Anil Chacko, Neil Desai, Inna Sekirov, David J Marchant, Pascal M Lavoie
Publikováno v:
The Journal of Infectious Diseases. 226:2064-2068
Health jurisdictions have seen a near-disappearance of respiratory syncytial virus (RSV) during the first year of the coronavirus disease 2019 (COVID-19) pandemic. Over this corresponding period, we report a reduction in RSV antibody levels and live
Publikováno v:
New Drug Development for Known and Emerging Viruses. :97-132
Autor:
Frederic, Reicherz, Rui Yang, Xu, Bahaa, Abu-Raya, Abdelilah, Majdoubi, Christina, Michalski, Liam, Golding, Aleksandra, Stojic, Marina, Vineta, Madison, Granoski, Zenon, Cieslak, Anil, Chacko, Neil, Desai, Inna, Sekirov, David J, Marchant, Pascal M, Lavoie
Publikováno v:
The Journal of infectious diseases.
Health jurisdictions have seen a near-disappearance of Respiratory Syncytial Virus (RSV) during the first year of the COVID-19 pandemic. Over a corresponding period, we report a reduction in RSV antibody levels and neutralization in women and infants
Autor:
Cameron D. Griffiths, Anil Kumar, Tom C. Hobman, Lionel D. Jensen, John E. McDonough, Jean-Laurent Casanova, Leanne M. Bilawchuk, David Proud, Theo J. Moraes, Steven Ogg, Bernard Thienpont, Yuchen Cen, Haeun Song, David J. Marchant, Wenming Duan, Cindy Lin, Farah Elawar, Kyla C. Jamieson
Publikováno v:
Nature. 583:615-619
Pneumonia resulting from infection is one of the leading causes of death worldwide. Pulmonary infection by the respiratory syncytial virus (RSV) is a large burden on human health, for which there are few therapeutic options1. RSV targets ciliated epi
Publikováno v:
Viruses, Vol 9, Iss 8, p 207 (2017)
Respiratory Syncytial Virus (RSV) that is propagated in cell culture is purified from cellular contaminants that can confound experimental results. A number of different purification methods have been described, including methods that utilize fast pr
Externí odkaz:
https://doaj.org/article/2cdb022c4c1a43a8b8741da497129a46
Autor:
Frederick G. West, Lionel D. Jensen, Ahmed K. Oraby, Quinten Kieser, David J. Marchant, Farah Elawar, Tyce N. Culp
Publikováno v:
Pharmacologytherapeutics. 220
RSV infection of the lower respiratory tract in infants is the leading cause of pediatric hospitalizations and second to malaria in causing infant deaths worldwide. RSV also causes substantial morbidity in immunocompromised and elderly populations. T